PicturaBio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series B1
- Latest Deal Amount
-
$9.1M
- Investors
-
12
PicturaBio General Information
Description
Developer of a pathogen detection platform designed to provide accurate, digital imaging-based identification of infectious diseases. The company's platform uses single-molecule fluorescent microscopy and image analysis with machine learning to detect an array of pathogens, enabling doctors to quickly identify unknown infections through respiratory viruses.
Contact Information
Website
www.pictura.bioCorporate Office
- Wood Centre for Innovation
- Quarry Road
- Oxford OX3 8SB
- England, United Kingdom
Corporate Office
- Wood Centre for Innovation
- Quarry Road
- Oxford OX3 8SB
- England, United Kingdom
PicturaBio Timeline
PicturaBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B1) | 23-Sep-2026 | $9.1M | Completed | Clinical Trials - General | ||
| 8. Early Stage VC | 07-Jul-2025 | Completed | Clinical Trials - General | |||
| 7. Early Stage VC | 11-Oct-2023 | Completed | Clinical Trials - General | |||
| 6. Accelerator/Incubator | 24-May-2023 | Completed | Clinical Trials - General | |||
| 5. Accelerator/Incubator | 01-Jan-2023 | Completed | Clinical Trials - General | |||
| 4. Grant | 17-Oct-2022 | Completed | Clinical Trials - General | |||
| 3. Seed Round | 15-Feb-2022 | Completed | Clinical Trials - General | |||
| 2. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 1. University Spin-Out | 20-Oct-2021 | Completed | Clinical Trials - General |
PicturaBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| Ordinary | ||||||||
| A Ordinary | 11,848 | $0.012272 | $258.93 | $258.93 | 1x | $258.93 | 37.87% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PicturaBio Signals
PicturaBio Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DTL Data Science | Venture Capital | Minority | ||
| Flu lab | Impact Investing | Minority | ||
| Impact Assets | Impact Investing | Minority | ||
| Defence and Security Accelerator | Accelerator/Incubator | Minority | ||
| Deeptech Labs | Accelerator/Incubator | Minority |
PicturaBio FAQs
-
When was PicturaBio founded?
PicturaBio was founded in 2021.
-
Where is PicturaBio headquartered?
PicturaBio is headquartered in Oxford, United Kingdom.
-
What is the size of PicturaBio?
PicturaBio has 15 total employees.
-
What industry is PicturaBio in?
PicturaBio’s primary industry is Diagnostic Equipment.
-
Is PicturaBio a private or public company?
PicturaBio is a Private company.
-
What is PicturaBio’s current revenue?
The current revenue for PicturaBio is .
-
How much funding has PicturaBio raised over time?
PicturaBio has raised $15.4M.
-
Who are PicturaBio’s investors?
DTL Data Science, Flu lab, Impact Assets, Defence and Security Accelerator, and Deeptech Labs are 5 of 12 investors who have invested in PicturaBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process